Anja Möricke - Concepedia

Author

Anja Möricke

Also Known As

A Möricke, A. Moricke, A. Möricke, Anja Moricke, Anja Möricke, Anja Möricke, Cornelia Eckert, Eckert, Cornelia, Joachim Gerß, Luca Lo Nigro

173

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover University of Lübeck St Anna Children's Hospital University Hospital Schleswig-Holstein Charité - Universitätsmedizin Berlin

About

Anja Möricke is an author at Medizinische Hochschule Hannover specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.8K
2	Health Sciences	5	5	750
3	Cell Biology	4	4	568
4	Public Health	1	1	127
5	Epidemiology	1	1	127

Anja Möricke

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, Blood	2010	778
The MLL recombinome of acute leukemias in 2017 Claus Meyer, Thomas Burmeister, Daniela Gröger, Leukemia	2017	670
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Anja Möricke, Alfred Reiter, Martin Zimmermann, Blood	2008	601
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 Anja Möricke, M Zimmermann, Alfred Reiter, Leukemia Hematological MalignancyLymphoid NeoplasiaAll-bfm Study GroupOncologyPediatric Hematology	2009	520
The MLL recombinome of acute leukemias in 2013 Claus Meyer, Jörg Hofmann, Thomas Burmeister, Leukemia	2013	506
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Martin Schrappe, Maria Grazia Valsecchi, Claus R. Bartram, Blood	2011	431
New insights to the MLL recombinome of acute leukemias Claus Meyer, Eric Kowarz, Jörg Hofmann, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaHematologyNew InsightsMedicine	2009	410
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, JAMA	2021	313
<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Martin Stanulla, Elif Dağdan, Markéta Žaliová, Journal of Clinical Oncology	2018	285
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, Blood	2016	274

Page 1